1. Home
  2. MNY vs NSRX Comparison

MNY vs NSRX Comparison

Compare MNY & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MoneyHero Limited

MNY

MoneyHero Limited

N/A

Current Price

$1.44

Market Cap

54.1M

Sector

N/A

ML Signal

N/A

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$4.62

Market Cap

53.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MNY
NSRX
Founded
2014
2019
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.1M
53.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MNY
NSRX
Price
$1.44
$4.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$4.00
$20.50
AVG Volume (30 Days)
45.0K
3.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$3.99
52 Week High
$2.40
$9.99

Technical Indicators

Market Signals
Indicator
MNY
NSRX
Relative Strength Index (RSI) 56.87 38.53
Support Level $1.31 N/A
Resistance Level $1.52 $6.39
Average True Range (ATR) 0.06 0.62
MACD 0.00 0.01
Stochastic Oscillator 50.00 25.40

Price Performance

Historical Comparison
MNY
NSRX

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: